Vinorelbine for rhabdomyosarcoma

A treatment and a condition, followed through the public trial records. Not medical advice. How a status is set

Phase 2 trial. Mid-stage trial in people. As of 19 Nov 2026, from 1 registered trial.

Why this status

  1. 14 May 2020: Trial registered, NCT04388839
  2. 29 Dec 2020: Trial started, NCT04388839

The trials

NCT04388839: Evolutionary Therapy for Rhabdomyosarcoma

State
Under way
Phase
Phase 2
People
12 taking part
Started
29 Dec 2020
Primary completion
Aug 2026
Arms
Arm A - First Strike
Results
None posted
  1. 14 May 2020: Trial registered
  2. 29 Dec 2020: Trial started

How the status changed

  1. 19 Nov 2026: First set: Phase 2 trial

About the treatment

Kind of treatment: Drug.

Registries searched: ClinicalTrials.gov, through 17 Nov 2026.